Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Fulminant drug-induced immune thrombocytopenia in polycystic kidney disease with cyst infection.

CEN case reports·2026
Same author

The history and clinical application of artificial talus in Japan.

International orthopaedics·2026
Same author

Association of Serum Phosphorus Levels With QT Prolongation in Patients With End-Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis Patients.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same author

Depth of the Dorsalis Pedis Artery Distal to the First and Second Tarsometatarsal Joints: A Cadaveric Anatomical Study.

Foot & ankle orthopaedics·2026
Same author

High-sensitivity Glasgow prognostic score and infection-related mortality in maintenance hemodialysis patients: 10-year outcomes of the Q-Cohort Study.

Clinical and experimental nephrology·2026
Same author

Long-term real-world effectiveness and safety of edoxaban in chronic thromboembolic pulmonary hypertension: a nationwide registry study.

Journal of thrombosis and haemostasis : JTH·2026

相关实验视频

Updated: May 10, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.8K

非常缓慢进展的微观多膜炎:与快速进展的形式进行比较分析.

Narumichi Iwamura1, Kanako Tsutsumi2, Yuki Ueno1

  • 1Department of Nephrology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, JPN.

Cureus
|June 14, 2024
PubMed
概括

微观多炎 (MPA) 可以缓慢或快速进展. 缓慢渐进的MPA表现出较少的炎症和功能逐渐下降,与快速渐进的形式不同.

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學.
  • 类风湿病学 类风湿病学
  • 免疫学 免疫学 免疫学

背景情况:

  • 微观多炎 (MPA) 通常呈现为与髓氧化酶抗中性粒细胞体抗体 (MPO-ANCA) 相关的快速进展型质炎 (RPGN).
  • 一大部分ANCA相关血管炎 (AAV) 病例表现出较慢,缓慢的进展到功能衰竭,这是一种不太了解的临床过程.
关键词:
与关联的血管炎 (AAV)慢性炎症是一种慢性炎症.微观的多炎 (mpa)骨髓氧化酶 - 抗中性粒细胞质抗体 (mpo-anca)快速进展的淋巴细胞炎 (rpgn)慢慢渐进的MPA慢慢地渐进的MPA

更多相关视频

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.7K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K

相关实验视频

Last Updated: May 10, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

4.8K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

2.7K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.9K